● Recruiting

Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

Condition: Coronary Artery Disease · Sponsor: Nanjing First Hospital, Nanjing Medical University

PhasePhase 4

Planned participants40

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

Effects of inclisiran + statins vs. statins on the morphology and vascular function of coronary vulnerable plaques, in order to provide a better treatment and more detailed imaging basis for the treatment of coronary vulnerable plaques.

This description comes directly from the study's public registry record.

Talk to the study team

Peina Meng, MD · 8615805199492 · 527114121@qq.com

Fei Ye, MD · 8618951670287 · doctor_ye@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

NanJing Frist Hospital

Nanjing, Jiangsu, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06338293